Maykl C. Snabes, MD, PhD, vice president of the clinical development of the Pharmaceuticalses BioSante, will present the review of the key analysis in LibiGel progress to maturity (the gel testosterone) program in Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And Breast Safe Study Libigel In Woman with Sexual pharmacy pill Disorder of the Desire inactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored investigator and consultant in University Connecticut School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre playwright.

The Conference of the news will is organized in Sunday, 15 June, 2008, prep which reporters invited to consider the announcement and discuss LibiGel and described analysis with Dr. Snabes.

BioSante CONDUCTS the safe analysis, in post-woman menopausal with hypoactive carnal health disorder of the desire (HSDD), on request USA. Food and Administration Medicine. The Request - in accordance immediately after call to more safe given from Endocrine Society, medical society to professions, that is focused in endocrine and metabolic sickness.

Dr. Snabes illustrious importance this preceding installing the analysis. “This clinical test too scrutinize the long-term effects testosterone in post-woman menopausal, can have existence one of first big, cardiovascular operated events, studies pre- approvals whirr undertaken in the absence of clear safe signal.”

BioSante EXPECTS that enrolled and is tested aproximately three thousandth posts-womans menopausal between age fifty and eighty and, which has at least once one cardiovascular factor of the risk. The pharmacy online Primary safe result respecting this test - y effect of the processing inn incidence heartily event, including cardiovascular bound death, heart attack, and blow. Incidence invasive breast cancer is a primary permissible endpoint co-, and investigators will also look the favourable breast breast cancer of the masses and non-invasives. The Patients will are evaluated for hirsutism, acne, and speech or reactions of the skin, as completely cooked as blood testosterone is justified during each visit of the analysis.

HSDD is CHARACTERIZED low libido and the general defect of the interest in sex. If safe endpoints counter and approves the medicine, LibiGel will come to be first commissioned processing specified for HSDD in menopausal woman. BioSante EXPECTS the approval certain time during 2010 or 2011.

The Feminine sexual dysfunction can arise out of numerous reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and successfully with testosterone for Multitude years though and to date not approved for this use. In terminated analysis Phase II LibiGel show excellent safety and efficiency. However, recently became interested cardiovascular and cancerous risk bound broad class drug, prep him potential therapy for FSD. The Safe analysis of the Phase III is intended to bind long-term safety LibiGel’s.

The Operated analysis studies the effect LibiGel in post-woman drugstore online menopausal in prescribed portion 300 micrograms per diem over Dozen months. BioSante is SPECIFICALLY focused in heartily event and number breast cancer. After Dozen plans of the months BioSante too focus for approval through New Application Medicine (NDA). requires BioSante to tag along the group of the analysis during additional fourty-eight months, after Usefulness NDA and potential affirmation to compare mate the warmhearted circumstance and breast cancer between group of the processing and corresponding to group of the womans, who get the gel

LibiGel - a gel 1% testosterone that woman enclose as presently as day, in their upper lever. Measured pea volume helium carries through skin quickly, from where he delivers the firm dose testosterone on blood.

Though testosterone thought-out as male hormone, he is moreover discovered in woman on horizontal surface forthcoming with their a hundred years. The Researchers believe that testosterone will justify, how remarkable autumn By the side of increasing of the age, can switch the feminine sexual desire. For instance, blackamoor in her has about royal line testosterone in the same proportion that broad in hits twenty.

Incidence HSDD also increases as age and after exact surgical procedures. Aproximately 14% premenopausal womans between age twenty and fourty-nine registered HSDD, in exhibit a contrast with 26% womans, online pharmacy tablet who surgical have deleted their ovaries. Similarly, incidence HSDD grows before 9% for “naturally” menopausal womans. LibiGel is INTENDED to restore the level testosterone in post-womans menopausal on on a, which are considered normal to finance sound libido.

The Results of the Analysis, which carry the earlier Place of ty information finally must lie to gourmandize return the safe enxiety for processing testosterone in woman and lead to approval of the first safe, efficient processing was specifically indicated toward HSDD in menopausal woman.